[Possible long-term prognosis in epidemiologically significant virus infections].
Identifieur interne : 000598 ( Main/Corpus ); précédent : 000597; suivant : 000599[Possible long-term prognosis in epidemiologically significant virus infections].
Auteurs : L. Gürtler ; W. Jilg ; H K KrausSource :
- Versicherungsmedizin [ 0933-4548 ] ; 1991.
English descriptors
- KwdEn :
- MESH :
- geographic , epidemiology : Germany.
- mortality : Deltaretrovirus Infections, HIV Infections, Hepatitis B, Hepatitis C, Virus Diseases.
- Cause of Death, Cross-Sectional Studies, Follow-Up Studies, Humans, Incidence.
Abstract
The long-range prognosis of viral diseases must be assessed differently according to their geographical occurrence. The genetic disposition, environmental factors and additional infectious diseases play a decisive part here. Vaccinations are the most important measures in the prevention of these infections. The spectrum of possible chemotherapeutic intervention for viral infectious diseases is very small, which usually makes specific treatment impossible. The most important infective viruses epidemiologically, which lead to persistent complications, are discussed in detail as follows: influenza virus, measles virus, human T-cell leukaemia virus, human immuno-deficiency virus, hepatitis B and C virus. In a discussion conclusions are drawn from the virologist's point of view for a possible long-range prognosis, which depends on the one hand on the infective agent and on the other on individual reactivity. The last chapter talks about insurance medical aspects of the most important infective viruses, which have already been discussed virologically. Some scientific developments are shown which could be future solutions of problems in diagnosis and prognosis. Such new developments could help insurance medical officers to important decision parameters for long-range prognosis, which are still largely missing at present.
PubMed: 1676199
Links to Exploration step
pubmed:1676199Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Possible long-term prognosis in epidemiologically significant virus infections].</title>
<author><name sortKey="Gurtler, L" sort="Gurtler, L" uniqKey="Gurtler L" first="L" last="Gürtler">L. Gürtler</name>
<affiliation><nlm:affiliation>Max-von-Pettenkofer-Institut, Universität München.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jilg, W" sort="Jilg, W" uniqKey="Jilg W" first="W" last="Jilg">W. Jilg</name>
</author>
<author><name sortKey="Kraus, H K" sort="Kraus, H K" uniqKey="Kraus H" first="H K" last="Kraus">H K Kraus</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1991">1991</date>
<idno type="RBID">pubmed:1676199</idno>
<idno type="pmid">1676199</idno>
<idno type="wicri:Area/Main/Corpus">000598</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000598</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Possible long-term prognosis in epidemiologically significant virus infections].</title>
<author><name sortKey="Gurtler, L" sort="Gurtler, L" uniqKey="Gurtler L" first="L" last="Gürtler">L. Gürtler</name>
<affiliation><nlm:affiliation>Max-von-Pettenkofer-Institut, Universität München.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jilg, W" sort="Jilg, W" uniqKey="Jilg W" first="W" last="Jilg">W. Jilg</name>
</author>
<author><name sortKey="Kraus, H K" sort="Kraus, H K" uniqKey="Kraus H" first="H K" last="Kraus">H K Kraus</name>
</author>
</analytic>
<series><title level="j">Versicherungsmedizin</title>
<idno type="ISSN">0933-4548</idno>
<imprint><date when="1991" type="published">1991</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cause of Death</term>
<term>Cross-Sectional Studies</term>
<term>Deltaretrovirus Infections (mortality)</term>
<term>Follow-Up Studies</term>
<term>Germany (epidemiology)</term>
<term>HIV Infections (mortality)</term>
<term>Hepatitis B (mortality)</term>
<term>Hepatitis C (mortality)</term>
<term>Humans</term>
<term>Incidence</term>
<term>Virus Diseases (mortality)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Deltaretrovirus Infections</term>
<term>HIV Infections</term>
<term>Hepatitis B</term>
<term>Hepatitis C</term>
<term>Virus Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cause of Death</term>
<term>Cross-Sectional Studies</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Incidence</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The long-range prognosis of viral diseases must be assessed differently according to their geographical occurrence. The genetic disposition, environmental factors and additional infectious diseases play a decisive part here. Vaccinations are the most important measures in the prevention of these infections. The spectrum of possible chemotherapeutic intervention for viral infectious diseases is very small, which usually makes specific treatment impossible. The most important infective viruses epidemiologically, which lead to persistent complications, are discussed in detail as follows: influenza virus, measles virus, human T-cell leukaemia virus, human immuno-deficiency virus, hepatitis B and C virus. In a discussion conclusions are drawn from the virologist's point of view for a possible long-range prognosis, which depends on the one hand on the infective agent and on the other on individual reactivity. The last chapter talks about insurance medical aspects of the most important infective viruses, which have already been discussed virologically. Some scientific developments are shown which could be future solutions of problems in diagnosis and prognosis. Such new developments could help insurance medical officers to important decision parameters for long-range prognosis, which are still largely missing at present.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">1676199</PMID>
<DateCompleted><Year>1991</Year>
<Month>08</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>10</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0933-4548</ISSN>
<JournalIssue CitedMedium="Print"><Volume>43</Volume>
<Issue>2</Issue>
<PubDate><Year>1991</Year>
<Month>Apr</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Versicherungsmedizin</Title>
<ISOAbbreviation>Versicherungsmedizin</ISOAbbreviation>
</Journal>
<ArticleTitle>[Possible long-term prognosis in epidemiologically significant virus infections].</ArticleTitle>
<Pagination><MedlinePgn>44-8</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The long-range prognosis of viral diseases must be assessed differently according to their geographical occurrence. The genetic disposition, environmental factors and additional infectious diseases play a decisive part here. Vaccinations are the most important measures in the prevention of these infections. The spectrum of possible chemotherapeutic intervention for viral infectious diseases is very small, which usually makes specific treatment impossible. The most important infective viruses epidemiologically, which lead to persistent complications, are discussed in detail as follows: influenza virus, measles virus, human T-cell leukaemia virus, human immuno-deficiency virus, hepatitis B and C virus. In a discussion conclusions are drawn from the virologist's point of view for a possible long-range prognosis, which depends on the one hand on the infective agent and on the other on individual reactivity. The last chapter talks about insurance medical aspects of the most important infective viruses, which have already been discussed virologically. Some scientific developments are shown which could be future solutions of problems in diagnosis and prognosis. Such new developments could help insurance medical officers to important decision parameters for long-range prognosis, which are still largely missing at present.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gürtler</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Max-von-Pettenkofer-Institut, Universität München.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jilg</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kraus</LastName>
<ForeName>H K</ForeName>
<Initials>HK</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Mögliche Langzeitprognose bei epidemiologisch bedeutsamen Virusinfektionen.</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Versicherungsmedizin</MedlineTA>
<NlmUniqueID>8803623</NlmUniqueID>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CitationSubset>X</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006800" MajorTopicYN="N">Deltaretrovirus Infections</DescriptorName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006526" MajorTopicYN="N">Hepatitis C</DescriptorName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName>
<QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>34</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1991</Year>
<Month>4</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1991</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1991</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">1676199</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000598 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000598 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= GrippeAllemagneV3 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:1676199 |texte= [Possible long-term prognosis in epidemiologically significant virus infections]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:1676199" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a GrippeAllemagneV3
This area was generated with Dilib version V0.6.35. |